Update August 2012

           Update, August 2012                                      Vol. 27, No. 7
IN THIS ISSUE:                                                      FOLLOW US:

Eva Chalas, Chair's Report
     Birth Weight & Breast Cancer Study
  Facebook   YouTube
20 CMEs at the Annual District II Meeting
Jr. Fellow Research Contests - NOW OPEN
ACA Means Victory For Women
The Liability Lowdown: Survey Results Are In!
Legislative Session Ends: How it Impacts YOU!  
LRANY & District II: A Partnership for Change  
17P Survey Results: We Asked, You Answered  
Is Your Hospital a 39 Weeks Best Practices Site?  
New ICD 10 Codes for Maternal Mortality Published  
Hands-on Obstetric Simulation Programs & Directory
FREE Audio Conference
Update Your OPMC Physician Profile - It's Mandatory
Attn: Junior Fellows - Remember to Vote
2012 Ob/Gyn Reporter Program at the ACM
Remembering Joseph E. Mather, Jr., MD, FACOG

Eva Chalas, MD, FACOG, FACS

Birth Weight and Breast Cancer Study
New research from the University of Texas Medical Branch at Galveston suggests that women who deliver big babies may have a greater risk of developing breast cancer in the future.

In a prospective long-term study of 400 women, results suggest that women who gave birth to a baby in the highest quintile for weight (over 8.25 pounds) were at significantly raised risk of developing breast cancer decades later. The study appears in the July 17 issue of PLoS One. In the same publication, the authors described the results of another study in which serum concentrations of estriol (E3), anti-estrogen alpha-fetoprotein (AFP), and pregnancy-associated plasma protein-A (PAPP-A) from nearly 24,000 women were measured during their pregnancies. These values were correlated to the birth weight of the child. Women whose child's birth weight was in the top quintile had highest levels of free estrogen. Linking the two studies, the authors hypothesized that women with large first-born children have higher levels of free estrogen, which may then be associated with a higher incidence of breast cancer decades later.

While the study offers interesting information, it is not clear what clinical impact it might have. Further, it is not clear how a physician might counsel a woman who is concerned about these findings.

For the moment, the best advice may be to simply adhere to ACOG guidelines regarding suggested weight gain and activity level during pregnancy, as adherence to these guidelines can result in maintenance of healthy weight for the mother and can reduce the risk of large-for-gestational age babies. In addition, women should undergo the recommended testing for gestational diabetes. Click here for Committee Opinion No. 504: Screening and Diagnosis of Gestational Diabetes Mellitus.


2012 ADMJoin us October 19-21 at the Grand Hyatt New York – and get 20 CMEs at the Annual District II Meeting (ADM)

Click here to register for the premier District II medical education event of the year. During the three day conference, you will obtain essential information that will help you respond to the ever-changing Ob/Gyn specialty. The Annual Meeting Program Committee has developed an outstanding program, featuring highly respected faculty from across the country.

Meeting highlights include:

  • Deposition Do's and Don'ts
  • ABOG Update
  • Modern Management of Pelvic Organ Prolapse
  • Optimizing OB Protocols
  • Apps - using your SMARTPHONE to Improve Safety & Communication

        To learn more about this year's program click here.

        Many thanks to Robert Silverman, MD, FACOG and Dena Goffman, MD, FACOG, this year’s Scientific Program Co-Chairs, for their academic guidance and course leadership. I look forward to seeing YOU at the ADM in the heart of the Big Apple
        October 19-21! 


        Iffath Abbasi Hoskins, MD Junior Fellow Research Day Contest
        Do you have an abstract from your resident or fellow research project you would like to share with nationally renowned physicians? The 2012 Iffath Abbasi Hoskins, MD Junior Fellow Research Day Contest is the opportunity for Junior Fellows of District II to showcase their research projects during this year's Annual District Meeting (ADM) being held October 19-21, 2012 at the Grand Hyatt New York. Contest awards include a $1,000 cash prize. All contestants are also offered a 1-day registration fee of $35 to attend the Annual Meeting on Saturday, October 20th. Click here for more information and to submit your research.

        2012 Donald F. Richardson Memorial Prize Paper Award - Call for Papers
        The Donald F. Richardson Memorial Prize Paper Award "Call for Papers" is currently underway. District II Junior Fellows are encouraged to submit a paper from basic science or clinical research for a chance to win $1,000, plus $750 for travel expenses to attend the 2013 Annual Clinical MeetingClick here for more information and to submit your research.

        2012 Junior Fellow Professor of the Year
        The District II Junior Fellow Task Force on Awards is currently seeking nominations for the 2012 Professor of the Year. This prestigious teaching award is presented annually to an ACOG Fellow Professor. Junior Fellow residents are asked to submit the name of a professor who has most positively impacted the Junior Fellows of District II. If you have a professor you believe is deserving of this award, nominate him or her today. Click here to enter your 2012 Junior Fellow Professor of the Year nominee.

        Contest Questions?
        Please contact the ACOG District II office at info@ny.acog.org.


        Key provisions of the Affordable Care Act (ACA) went into effect August 1, and women with employer-sponsored health insurance will now have access to critical preventative care with no co-pays or deductibles. This important coverage will now include:

        • Gestational diabetes screening
        • HPV DNA testing
        • STI counseling and HIV screening and counseling
        • Contraception and contraceptive counseling
        • Breastfeeding support, supplies, and counseling
        • Domestic violence screening

        For more information on ACA, click here.

        Click here for ACOG’s reaction to the recent ACA decision.


        Results are in from the 2012 ACOG Survey on Professional Liability. This latest survey reflects an ongoing negative liability environment in that 51% of ob-gyn survey respondents have made one or more changes to their practice as a result of the affordability and/or availability of professional liability insurance, and almost 58% have made one or more changes to their practice as a result of the risk or fear of professional liability claims or litigation. Click here to see District II’s survey results. Click here for the National summary.


        Legislative Session Ends: How it Impacts YOU!
        The New York State Legislative Session ended in Albany on June 22. Key legislative decisions impacting the field of Ob/Gyn can be found by clicking here.

        LRANY & District II: A Partnership for Change
        The Lawsuit Reform Alliance of New York (LRANY) is a broad based coalition of NY business leaders, professionals and consumers who are committed to changing our state’s burdensome and expensive legal system to help create more jobs and energize NY’s economy. District II is proud of the great working relationship with LRANY throughout the 2012 legislative session. Advocating together, District II and LRANY have stopped regressive medical liability legislation from becoming law. Working as a team, we will continue our fight for comprehensive tort reform in New York State. To become a member (free) of LRANY, click here. To take a brief survey, click here.


        17P Survey Results: We Asked, You Answered
        In June, ACOG District II asked you to complete a brief provider survey on 17P administration as part of its latest education in the Preventing Preterm Birth series. The results are in and here is what you had to say:

        • 62% prescribe 17-alpha hydroxyprogesterone caproate in any form for the prevention of recurrent preterm birth in women with a history of prior spontaneous preterm birth
        • 90% prescribe compounded 17P
        • 48% prescribe Makena
        • 50% choose either formulation based on insurance coverage issues
        • Despite subsequent pricing clarifications, nearly 34% will not prescribe Makena because of the initial controversy at its launch.
        • Over 75% cite that more barriers exist when prescribing, recommending, or referring Makena as opposed to compounded 17P. These barriers include reimbursement failure on the part of private insurers and Medicaid, and a one week or longer delay after the prescription is written and approved.

        More data is needed. If you are interested in adding your thoughts, please complete our survey by clicking here.

        Is Your Hospital a 39 Weeks Best Practices Site? 
        ACOG District II would like to extend a warm “thank you” to the Level 3 and RPC hospital pilot sites participating in the Elimination of Non-Medically Indicated Deliveries (NMID) Prior to 39 Weeks initiative. The following hospitals have implemented model policies on this issue and have been instrumental in helping District II evaluate and understand best practice standards for eliminating NMID prior to 39 weeks:

        • Lenox Hill Hospital, New York, NY
        • Lincoln Medical and Mental Health Center, Bronx, NY
        • Lutheran Medical Center, Brooklyn, NY
        • Mount Sinai Medical Center, Manhattan, NY
        • North Shore University Hospital, Manhasset, NY
        • Winthrop University Hospital, Mineola, NY

        Each of these hospitals participated in lengthy conference calls with ACOG District II to explain how their protocol was developed and implemented as well as how they overcame any barriers and challenges. District II will utilize lessons learned from these model policies to develop education for obstetric providers, clinical staff, and hospitals across New York State.

        In addition, these hospitals have rolled out a targeted patient education campaign with the help of ACOG District II. The March of Dimes Why the Last Weeks of Pregnancy Count pamphlet, Late Preterm Brain Development card and an ACOG District II developed “I made it to 39 weeks” postcard are being used to encourage patients to reach 39 weeks of pregnancy. For more information on this topic, visit the ACOG District II website by clicking here.

        New ICD 10 Codes for Maternal Mortality Published
        Click here for this new publication, which will help Maternal Mortality Review (MMR) teams establish definitions and standardize MMR to better analyze and explore cause of death.


        Hands-on Obstetric Simulation Programs & Directory
        ACOG District II is developing a general directory of Obstetric Simulation Programs from across the state. The directory along with valuable materials and resources will be given to each participant attending the hands-on obstetric simulation program during the Annual District Meeting this October. The program features include hands-on obstetric simulation activities that will address both common and rare obstetric emergencies and a review of the most current evidence-based treatment recommendations.

        Please click here to provide your institution's obstetric simulation training program information. This information will be featured in the directory.

        To learn more about the Annual District Meeting and Obstetric Simulation Program, click here.

        FREE Audio Conference
        Please join us Wednesday, August 15, 2012, 12:00 pm - 1:30 pm for a FREE audio conference on the MOREOB Program. MOREOB (Managing Obstetrical Risk Efficiently) is a three-year, comprehensive patient safety improvement & professional development program for providers and administrators in hospital obstetric units. To register, click here.


        Update Your OPMC Physician Profile - It's Mandatory
        Pursuant to Public Health Law, physicians must report information for inclusion in the Department of Health Physician Profile. As a condition of registration renewal, physicians must update his/her profile within six (6) months prior to the expiration date of the physician's registration period.

        Click here for more.


        Attention Junior Fellows
        VOTE for your 2012-2013 District II Junior Fellow Officers
        Voting opens August 1! 
        Click here for voting instructions 
        Click here to see the District II nominees
        Click here to vote

        2012 Ob/Gyn Reporter Program at the ACM
        This year's Ob-Gyn Reporter Program was held at the 2012 ACOG Annual Clinical Meeting (ACM) in San Diego, California. The Reporter Program, which is sponsored by Teva Women's Health, promotes connections between Junior Fellows from the United States, Japan, and South America. District II Junior Fellows who attended the 2012 ACM as Ob/Gyn Resident Reporters were Lori Homa, MD, David Kulak, MD, Jovana Lekovic-Bijelic, MD, Sarah Morocco, MD, and Nwamaka M. Onwugbenu, MD. 

        Click here to read the experiences of our District's Junior Fellows at the 2012 ACM.  

          IN MEMORIAM

        Remembering Joseph E. Mather, Jr., MD, FACOG




        Click here